Aurobindo Pharma Ltd.

Financial

	Aurobindo Pharma	Abbott India	Alkem Laboratories
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	865.0 .	n/a	185.0 .
Number of ANDA's Approved By USFDA	733.0 .	n/a	160.0 .
US DMF Filings	310.0 .	n/a	n/a
Europe DMF Filings	2109.0 .	n/a	n/a
R&D as a % of Total Sales	4.7 %	0.02 %	3.5 %
Financials
5 yr Average ROE	12.72 %	30.11 %	17.38 %
5yr average Equity Multiplier	1.46	1.43	1.39
5yr Average Asset Turnover Ratio	0.68	1.14	0.86
5yr Avg Net Profit Margin	12.5 %	18.53 %	14.54 %
Price to Book	1.99	15.21	5.52
P/E	19.15	44.33	28.96
5yr Avg Cash Conversion Cycle	-46.37 Days	-46.68 Days	-61.46 Days
Inventory Days	59.62 Days	45.22 Days	56.11 Days
Days Receivable	30.33 Days	19.34 Days	44.62 Days
Days Payable	121.28 Days	109.21 Days	122.42 Days
5yr Average Interest Coverage Ratio	43.54	97.37	24.48
5yr Avg ROCE	15.27 %	38.77 %	22.76 %
5yr Avg Operating Profit Margin	19.22 %	23.42 %	18.44 %
5 yr average Debt to Equity	0.19	0.0	0.18
5yr CAGR Net Profit	-8.16 %	15.41 %	6.44 %
5yr Average Return on Assets	8.64 %	21.03 %	12.47 %
Shareholdings
Promoter Holding	51.82 %	74.99 %	53.04 %
Share Pledged by Promoters	17.08 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.01 %	0.0	-4.1 %
Change in Mutual Fund Holding (3 Yrs)	9.14 %	2.93 %	8.82 %

Business

	Aurobindo Pharma	Abbott India	Alkem Laboratories
Product Wise Break-Up	Product Wise Break-Up Formulations 88.36 Active Pharmaceutical Ingredient (API) 11.64 Vitamin, Minerals & Nutrition 0 Hepatoprotectives 0 Hormones 0 Anti Diabetic 0 Central Nervous System 0 Respiratory 0 Vaccines 0 cardiovascular system 0 Derma 0 Anti-Infectives 0 Metabolic 0 Women`s health 0 Gastro Intestinal 0 Pain 0 Pharmaceutical 0	Product Wise Break-Up Formulations 0 Hepatoprotectives 0 Women`s health 0 Hormones 11.59 Central Nervous System (CNS) 12.65 Vaccines 0 Derma 0 Anti-Infectives 0 Metabolic 0 Pain 0 Pharmaceutical 0 Vitamin, Minerals & Nutrition 0 Respiratory 0 Gastro Intestinal 25.46 Active Pharmaceutical Ingredient (API) 0 cardiovascular system 0 Anti Diabetic 42.82 Others 7.48	Product Wise Break-Up Formulations 0 Hepatoprotectives 0 Women`s health 0 Hormones 0 Central Nervous System 0 Vaccines 0 Derma 0 Anti-Infectives 0 Metabolic 0 Pain 0 Pharmaceutical 100.0 Vitamin, Minerals & Nutrition 0 Respiratory 0 Gastro Intestinal 0 Active Pharmaceutical Ingredient (API) 0 cardiovascular system 0 Anti Diabetic 0
Location Wise Break-Up	Location Wise Break-Up USA 44.3 Europe 29.7 Rest of the World 17.0 India 9.0	Location Wise Break-Up Rest of the World 1.19 India 98.81 USA 0 Europe 0	Location Wise Break-Up Rest of the World 0 India 67.19 USA 31.26 Europe 0 Others 1.55
Asset Break-Up	Asset Break-Up India 65.14 USA 18.21 Europe 7.85 Others 8.8	-	Asset Break-Up India 70.19 USA 28.27 Europe 0 Others 1.54

Aurobindo Pharma Ltd.

SIGN UP FOR FREE